Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TLGT

Teligent (TLGT) Stock Price, News & Analysis

Teligent logo

About Teligent Stock (NASDAQ:TLGT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.01
$0.05
52-Week Range
N/A
Volume
6,460 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over-the-counter, and cosmetic markets. The company was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.

Receive TLGT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teligent and its competitors with MarketBeat's FREE daily newsletter.

TLGT Stock News Headlines

IDT Corp. Cl B
The Recession Already Started, Are You Prepared?
Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Americans are shifting savings out of traditional accounts to protect what they’ve earned. If you’re concerned about inflation, rising debt, or a falling dollar, this free Wealth Protection Kit includes three timely reports to help you prepare for what’s coming next.
See More Headlines

TLGT Stock Analysis - Frequently Asked Questions

Teligent, Inc. (NASDAQ:TLGT) issued its quarterly earnings data on Monday, August, 16th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by $0.01. The business earned $10.43 million during the quarter.

Teligent shares reverse split before market open on Thursday, May 28th 2020. The 1-10 reverse split was announced on Wednesday, May 27th 2020. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Teligent investors own include Meta Platforms (META), Novavax (NVAX), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), TherapeuticsMD (TXMD), AbbVie (ABBV) and Alphabet (GOOG).

Company Calendar

Last Earnings
8/16/2021
Today
6/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TLGT
Employees
2,357
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:TLGT) was last updated on 6/4/2025 by MarketBeat.com Staff
From Our Partners